Answers are grounded in this paper and cite their sources.
Traumatic spinal cord injury (SCI) is a microenvironment-driven pathological process in which excitotoxicity, oxidative stress, neuroinflammation, and fibrotic scarring collectively impede neural regeneration. Conventional therapies largely fail to reverse this hostile niche, limiting functional recovery. Biofunctional biomaterials have emerged as an integrative strategy that bridges structural reconstruction with microenvironmental reprogramming. By combining physical scaffolding with spatiotemporally controlled delivery of bioactive cues, these systems actively modulate key pathological processes and promote coordinated neural repair. Here, we summarize recent advances in scaffold-based materials, injectable hydrogels, and nanoplatforms, highlighting their roles in regulating inflammation, redox imbalance, and extracellular matrix remodeling. We further propose a conceptual shift in which biomaterials are viewed as active regulators of the injury microenvironment rather than passive carriers. Emerging trends—including multifunctional integration, smart responsiveness, advanced biofabrication, and convergence with gene editing and single-cell technologies—are expected to drive the transition toward precision regenerative therapies. Collectively, this review outlines a paradigm shift from structural repair to microenvironmental engineering, offering a framework for the rational design of next-generation biomaterials for SCI repair.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: